曲伏前列素滴眼液治疗原发性开角型青光眼49例疗效观察

摘要

目的 探讨曲伏前列素滴眼液治疗原发性开角型青光眼的疗效.方法 选择医院2016年1月至2017年1月收治的原发性开角型青光眼患者98例,按随机数字表法分为对照组和观察组,各49例.对照组采用噻吗洛尔滴眼液治疗,早晚各给药1次,每次1滴;观察组采用曲伏前列素滴眼液治疗,晚上给药1次,每次1滴.均治疗8周.结果 观察组治疗总有效率为95.92%,明显高于对照组的79.59%(P0.05),治疗8周观察组眼压水平显著低于对照组(P 0. 05 ) , after 8 weeks of treatment, the IOP level of the observation group was significantly lower than that of the control group ( P < 0. 05 ) . Conclusion Travoprost Eye Drops is effective in the treatment of primary open-angle glaucoma, it can effectively reduce IOP level, improve clinical symptoms, shorten the course of treatment with less adverse reactions and high safety.